Nitric oxide, lipid peroxidation, and antioxidant enzyme levels in epileptic children using valproic acid

Brain Research

Volumn 1297, Issue , 2009, Pages 194-197

  Peker, Erdal ^a   Oktar, Süleyman ^b   Ari, Mustafa ^b   Kozan, Ramazan ^b   Doǧan, Murat ^a   Çaǧan, Eren ^a   Söǧüt, Sadik ^b  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Antioxidant enzyme; Children; Epilepsy; Nitric oxide; Valproic acid

Indexed keywords

CATALASE; MALONALDEHYDE; NITRIC OXIDE; NITROUS OXIDE; SUPEROXIDE DISMUTASE; VALPROIC ACID;

ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATION REDUCTION REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPECTROPHOTOMETRY;

ANTICONVULSANTS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CATALASE; CHILD; CHILD, PRESCHOOL; ENZYME ASSAYS; ENZYMES; EPILEPSY; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; SPECTROPHOTOMETRY; SUPEROXIDE DISMUTASE; VALPROIC ACID;

EID: 71749119931     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.08.048     Document Type: Article

References (28)

1. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 114-121
2. Aycicek A., and Iscan A. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children. Eur. Neurol. 57 (2007) 65-69
3. Bosnak M., Ayyildiz M., Yildirim M., and Agar E. The role of nitric oxide in the anticonvulsant effects of pyridoxine on penicillin-induced epileptiform activity in rats. Epilepsy. Res. 76 (2007) 49-59
4. Cengiz M., Yuksel A., and Seven M. The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children. Pharmacol. Res. 41 (2000) 423-425
5. Cortas N.K., and Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36 (1990) 1440-1443
6. Czuczwar S.J., Tutka P., Klonowski P., and Kleinrok Z. N(G)-nitro-l-arginine impairs the anticonvulsive action of ethosuximide against pentylenetetrazol. Eur. J. Pharmacol. 366 (1999) 137-142
7. Faradji H., Rousset C., Debilly G., Vergnes M., and Cespuglio R. Sleep and epilepsy: a key role for nitric oxide?. Epilepsia 41 (2000) 794-801
8. Hamed S.A., and Abdellah M.M. Trace elements and electrolytes homeostasis and their relation to antioxidant enzyme activity in brain hyperexcitability of epileptic patients. J. Pharmacol. Sci. 96 (2004) 349-359
9. Itoh K., and Watanabe M. Paradoxical facilitation of pentylenetetrazole-induced convulsion susceptibility in mice lacking neuronal nitric oxide synthase. Neuroscience 159 (2009) 735-743
10. Kamida T., Takeda Y., Fujiki M., Abe T., Abe E., and Kobayashi H. Nitric oxide synthase and NMDA receptor expressions in cavernoma tissues with epileptogenesis. Acta Neurol. Scand. 116 (2007) 368-373
11. Karabiber H., Yakinci C., Durmaz Y., Temel I., and Mehmet N. Serum nitrite and nitrate levels in epileptic children using valproic acid or carbamazepine. Brain Dev. 26 (2004) 15-18
12. Kirkby R.D., Carroll D.M., Grossman A.B., and Subramaniam S. Factors determining proconvulsant and anticonvulsant effects of inhibitors of nitric oxide synthase in rodents. Epilepsy. Res. 24 (1996) 91-100
13. Michaelis M., Michaelis U.R., Fleming I., Suhan T., Cinatl J., Blaheta R.A., Hoffmann K., Kotchetkov R., Busse R., Nau H., and Cinatl Jr. J. Valproic acid inhibits angiogenesis in vitro and in vivo. Mol. Pharmacol. 65 (2004) 520-527
14. Nagatomo I., Akasaki Y., Uchida M., Tominaga M., Hashiguchi W., and Takigawa M. Effects of combined administration of zonisamide and valproic acid or phenytoin to nitric oxide production, monoamines and zonisamide concentrations in the brain of seizure-susceptible EL mice. Brain Res. Bull. 53 (2000) 211-218
15. Pereira de Vasconcelos A., Marescaux C., and Nehlig A. Age-dependent regulation of seizure activity by nitric oxide in the developing rat. Brain Res. Dev. Brain Res. 107 (1998) 315-319
16. Rundfeldt C., Koch R., Richter A., Mevissen M., Gerecke U., and Löscher W. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. Eur. J. Pharmacol. 274 (1995) 73-81
17. Ribeiro L.R., Fighera M.R., Oliveira M.S., Furian A.F., Rambo L.M., Ferreira A.P., Saraiva A.L., Souza M.A., Lima F.D., Magni D.V., Dezengrini R., Flores E.F., Butterfield D.A., Ferreira J., dos Santos A.R., Mello C.F., and Royes L.F. Methylmalonate-induced seizures are attenuated in inducible nitric oxide synthase knockout mice. Int. J. Dev. Neurosci. 27 (2009) 157-163
18. Royes L.F., Fighera M.R., Furian A.F., Oliveira M.S., Fiorenza N.G., Petry J.C., Coelho R.C., and Mello C.F. The role of nitric oxide on the convulsive behavior and oxidative stress induced by methylmalonate: an electroencephalographic and neurochemical study. Epilepsy Res. 73 (2007) 228-237
19. Sandirasegarane L., Mikler J.R., Tuchek J.M., and Sulakhe P.V. Enhanced forebrain nitric oxide synthase activity in epileptic fowl. Brain Res. 735 (1996) 311-313
20. Schulpis K.H., Lazaropoulou C., Regoutas S., Karikas G.A., Margeli A., Tsakiris S., and Papassotiriou I. Valproic acid monotherapy induces DNA oxidative damage. Toxicology 217 (2006) 228-232
21. Sobaniec W., Solowiej E., Kulak W., Bockowski L., Kuzia J.S.K., and Artemowicz B. Evaluation of the influence of antiepileptic therapy on antioxidant enzyme activity and lipid peroxidation in erythrocytes of children with epilepsia. J. Child. Neurol. 21 (2006) 558-562
22. Sołowiej E., and Sobaniec W. The effect of antiepileptic drug therapy on antioxidant enzyme activity and serum lipid peroxidation in young patients with epilepsy. Neurol. Neurochir. Pol. 37 (2003) 991-1003 [Article in polish]
23. Sun Y., Oberley L.W., and Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34 (1988) 497-500
24. Tutka P., Luszczki J., Kleinrok Z., Arent K., and Wielosz M. Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice. J. Neural. Transm. 109 (2002) 455-466
25. Verrotti A., Basciani F., Trotta D., Pomilio M.P., Morgese G., and Chiarelli F. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res. 48 (2002) 71-75
26. Verrotti A., Scardapane A., Franzoni E., Manco R., and Chiarelli F. Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res. 78 (2008) 171-177
27. Wallace S.J. A comparative review of the adverse effects of anticonvulsant in children with epilepsy. Drug Safe 15 (1996) 378-393
28. Wasowicz W., Neve J., and Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin. Chem. 39 (1993) 2522-2526